Shopping Cart
Remove All
Your shopping cart is currently empty
ETTAC-2 acetate is a selective PROTAC degrader targeting LRG1 (Leucine-rich α-2 glycoprotein 1), inhibiting the TGF-β-Smad3 signalling pathway to slow renal fibrosis progression.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $140 | - | In Stock | |
| 5 mg | $320 | - | In Stock | |
| 10 mg | $480 | - | In Stock | |
| 25 mg | $820 | - | In Stock | |
| 50 mg | $1,230 | - | In Stock |
| Description | ETTAC-2 acetate is a selective PROTAC degrader targeting LRG1 (Leucine-rich α-2 glycoprotein 1), inhibiting the TGF-β-Smad3 signalling pathway to slow renal fibrosis progression. |
| Synonyms | ETTAC2 acetate |
| Color | White |
| Appearance | Solid |
| Sequence | Lenalidomide-(CC)-Gly-Gly-Glu-Ser-Tyr-Ser-Ala-Lys-His-Arg-Ile-Met-Leu-Thr |
| Sequence Short | Lenalidomide-(CC)-GGESYSAKHRIMLT |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | H2O: 25 mg/mL |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.